Search details
1.
Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases.
Proc Natl Acad Sci U S A
; 119(15): e2120787119, 2022 04 12.
Article
in English
| MEDLINE | ID: mdl-35385357
2.
The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients.
Cancer Immunol Immunother
; 73(7): 135, 2024 May 17.
Article
in English
| MEDLINE | ID: mdl-38758239
3.
Two novel high-risk adult B-cell acute lymphoblastic leukemia subtypes with high expression of CDX2 and IDH1/2 mutations.
Blood
; 139(12): 1850-1862, 2022 03 24.
Article
in English
| MEDLINE | ID: mdl-34695176
4.
Outcomes of transplant-eligible patients with myelodysplastic syndrome with excess blasts registered in an observational study: The JALSG-CS11-MDS-SCT.
Ann Hematol
; 103(1): 307-320, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37940714
5.
Efficacy of elotuzumab for multiple myeloma deteriorates after daratumumab: a multicenter retrospective study.
Ann Hematol
; 2024 Mar 16.
Article
in English
| MEDLINE | ID: mdl-38492020
6.
Utility of allogeneic stem cell transplantation for adult Ph+ALL with complete molecular remission.
Am J Hematol
; 99(5): 806-815, 2024 May.
Article
in English
| MEDLINE | ID: mdl-38314662
7.
Development and evaluation of a rapid one-step high sensitivity real-time quantitative PCR system for minor BCR-ABL (e1a2) test in Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL).
Jpn J Clin Oncol
; 54(2): 153-159, 2024 Feb 07.
Article
in English
| MEDLINE | ID: mdl-37986553
8.
Clinical outcomes of second-generation tyrosine kinase inhibitors versus imatinib in older patients with CML.
Cancer Sci
; 114(3): 995-1006, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36336963
9.
Functional inhibition of MEF2 by C/EBP is a possible mechanism of leukemia development by CEBP-IGH fusion gene.
Cancer Sci
; 114(3): 781-792, 2023 Mar.
Article
in English
| MEDLINE | ID: mdl-36341510
10.
U-KIM-1 as a predictor of treatment response in lupus nephritis.
Lupus
; 32(1): 54-62, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36305170
11.
Iguratimod versus salazosulfapyridine in rheumatoid arthritis patients with an inadequate response to methotrexate: Adjusted with propensity score matching.
Mod Rheumatol
; 33(3): 472-480, 2023 Apr 13.
Article
in English
| MEDLINE | ID: mdl-35695707
12.
Deletion of Antigen-Presenting Cells in Lipopolysaccharide-Induced Acute Kidney Injury (AKI) Affects the Exacerbation and Repair in AKI.
Curr Issues Mol Biol
; 44(11): 5655-5665, 2022 Nov 14.
Article
in English
| MEDLINE | ID: mdl-36421667
13.
Phase 1/2 study evaluating the safety and efficacy of DSP-7888 dosing emulsion in myelodysplastic syndromes.
Cancer Sci
; 113(4): 1377-1392, 2022 Apr.
Article
in English
| MEDLINE | ID: mdl-34932235
14.
Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma.
Cancer Sci
; 113(2): 660-673, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34837284
15.
Novel prognostic predictor of haemoglobin-platelet index in diffuse large B-cell lymphoma, not otherwise specified: Anaemia and thrombocytopenia are associated with IL-6 production in lymphoma cells.
Br J Haematol
; 198(2): 360-372, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35451502
16.
Chlorpromazine cooperatively induces apoptosis with tyrosine kinase inhibitors in EGFR-mutated lung cancer cell lines and restores the sensitivity to gefitinib in T790M-harboring resistant cells.
Biochem Biophys Res Commun
; 626: 156-166, 2022 10 20.
Article
in English
| MEDLINE | ID: mdl-35994825
17.
The Satb1 protein directs hematopoietic stem cell differentiation toward lymphoid lineages.
Immunity
; 38(6): 1105-15, 2013 Jun 27.
Article
in English
| MEDLINE | ID: mdl-23791645
18.
Venetoclax plus azacitidine in Japanese patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy.
Jpn J Clin Oncol
; 52(1): 29-38, 2022 Jan 03.
Article
in English
| MEDLINE | ID: mdl-34739075
19.
Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study.
Br J Haematol
; 192(1): 190-199, 2021 01.
Article
in English
| MEDLINE | ID: mdl-33152120
20.
Plateau is a prognostic factor of lenalidomide therapy for previously treated multiple myeloma.
Hematol Oncol
; 39(3): 349-357, 2021 Aug.
Article
in English
| MEDLINE | ID: mdl-33724498